National Academy of Sciences elects four MIT professors for 2018
Finkelstein, Kardar, Wen, and Zhang honored for research achievements.
Search Stories
Researchers advance CRISPR-based tool for diagnosing disease
With SHERLOCK, a strip of paper can now indicate presence of pathogens, tumor DNA, or any genetic signature of interest.
Study: Fragile X syndrome neurons can be restored
Whitehead Institute researchers are using a modified CRISPR/Cas9-guided activation strategy to investigate the most frequent cause of intellectual disability in males.
Polina Anikeeva and Feng Zhang awarded 2018 Vilcek Prize
Prize recognizes contributions to biomedical research made by immigrant scientists.
Reading and writing DNA
Department of Biology kicks off IAP seminar series with a lecture by synthetic-biology visionary George Church.
CRISPR-carrying nanoparticles edit the genome
New delivery system developed by MIT team deletes disease-causing genes and reduces cholesterol.
Researchers engineer CRISPR to edit single RNA letters in human cells
“REPAIR” system edits RNA, rather than DNA; has potential to treat diseases without permanently affecting the genome.
New technique scours the genome for genes that combat disease
Biological engineers identify genes that protect against protein linked to Parkinson’s disease.
Ten researchers from MIT and Broad receive NIH Director’s Awards
Awards support high-risk, high-impact biomedical research.
New target for treating “undruggable” lung cancer
Drug already in clinical trials may be effective on some aggressive adenocarcinomas.
Gene-editing technology developer Feng Zhang awarded $500,000 Lemelson-MIT Prize
MIT associate professor and member of the Broad Institute and McGovern Institute recognized for commitment to invention, collaboration, and mentorship.
Feng Zhang to share Albany Medical Prize
Five recipients honored for their fundamental and complementary accomplishments related to CRISPR-Cas9.
Q&A: Running a company in an era of “crazy technological progress”
New book by Andrew McAfee and Erik Brynjolfsson surveys tech’s challenges for business.
President L. Rafael Reif's charge to the Class of 2017
"One of today’s great challenges is how to help society navigate the unintended impact of technology itself," Reif tells more than 2,800 new graduates.
Deploying therapeutic payloads to cells
Mark Bathe develops molecular packages for targeted delivery of drugs, vaccines, and gene-editing tools.